日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement

更正:LY6K通过CAV-1介导的ERK1/2信号通路增强促进胶质母细胞瘤的致瘤性

Aspartate β-hydroxylase Regulates Expression of Ly6 Genes

天冬氨酸β-羟化酶调控Ly6基因的表达

Madiha Kanwal, Jana Smahelova, Barbora Ciharova, Shweta Dilip Johari, Jaroslav Nunvar, Mark Olsen, Michal Smahel

LY6K depletion modulates TGF-β and EGF signaling

LY6K 缺失调节 TGF-β 和 EGF 信号传导

Sujeong Park,Doyeon Park,Sora Han,Ga Eun Chung,Sujung Soh,Hye In Ka,Hyun Jeong Joo,Young Yang

Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K

ZNF252P-AS1 的下调通过与 miR-324-3p 结合下调 LY6K 来缓解卵巢癌的进展。

Geng, Li; Wang, Zhongqiu; Tian, Yongju

Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma

LY6K和CDCA1表达对食管鳞状细胞癌患者预后的影响

Oguma, Junya; Ozawa, Soji; Sakakibara, Terue; Kajiwara, Hiroshi; Nakamura, Naoya; Makuuchi, Hiroyasu

LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement

LY6K通过CAV-1介导的ERK1/2信号通路增强促进胶质母细胞瘤的肿瘤发生。

Sastry, Namratha G; Wan, Xuechao; Huang, Tianzhi; Alvarez, Angel A; Pangeni, Rajendra P; Song, Xiao; James, Charles David; Horbinski, Craig M; Brennan, Cameron W; Nakano, Ichiro; Hu, Bo; Cheng, Shi-Yuan

Identification of immunogenic LY6K long peptide encompassing both CD4(+) and CD8(+) T-cell epitopes and eliciting CD4(+) T-cell immunity in patients with malignant disease

鉴定出包含 CD4(+) 和 CD8(+) T 细胞表位并能诱导恶性肿瘤患者产生 CD4(+) T 细胞免疫的免疫原性 LY6K 长肽

Tomita, Yusuke; Yuno, Akira; Tsukamoto, Hirotake; Senju, Satoru; Kuroda, Yasuhiro; Hirayama, Masatoshi; Imamura, Yuya; Yatsuda, Junji; Sayem, Mohammad Abu; Irie, Atsushi; Hamada, Akinobu; Jono, Hirofumi; Yoshida, Koji; Tsunoda, Takuya; Daigo, Yataro; Kohrogi, Hirotsugu; Yoshitake, Yoshihiro; Nakamura, Yusuke; Shinohara, Masanori; Nishimura, Yasuharu

LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling

基于整合全基因组分析,LY6K是膀胱癌中的一种新型分子靶点。

R Matsuda ,H Enokida, T Chiyomaru, N Kikkawa, T Sugimoto, K Kawakami, S Tatarano, H Yoshino, K Toki, Y Uchida, K Kawahara, K Nishiyama, N Seki, M Nakagawa